Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 183

1.

APRIL is Involved in the Proliferation and Metastasis of Acute Lymphoblastic Leukemia Cells.

Sun B, Xia Z, Cai F, Wang P, Xu M, Wu Y.

J Pediatr Hematol Oncol. 2018 Nov;40(8):588-593. doi: 10.1097/MPH.0000000000001198.

PMID:
29697578
2.

Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population.

Zhong Z, Feng SZ, Xu RC, Li ZJ, Huang FX, Yin PR, Liu WT, Wang M, Shi DC, Zhou Q, Yu XQ, Li M.

J Gene Med. 2017 Jun;19(6-7). doi: 10.1002/jgm.2966.

PMID:
28636766
3.

A New Animal Model of Gastric Lymphomagenesis: APRIL Transgenic Mice Infected by Helicobacter Species.

Floch P, Izotte J, Guillemaud J, Sifré E, Costet P, Rousseau B, Laur AM, Giese A, Korolik V, Mégraud F, Dubus P, Hahne M, Lehours P.

Am J Pathol. 2017 Jul;187(7):1473-1484. doi: 10.1016/j.ajpath.2017.03.004. Epub 2017 Apr 29.

PMID:
28460208
4.

Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.

Deng B, Liu XN, Li X, Zhang X, Quan C, Chen XJ.

J Neuroimmunol. 2017 Apr 15;305:84-91. doi: 10.1016/j.jneuroim.2017.01.012. Epub 2017 Jan 26.

PMID:
28284352
5.

Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation.

Liu Z, Liao L, Cao Z, Chen X, Du J.

Oncol Rep. 2017 Feb;37(2):754-760. doi: 10.3892/or.2016.5339. Epub 2016 Dec 28.

6.

APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus.

Namazi S, Tajik N, Ziaee V, Sadr M, Soltani S, Rezaei A, Zoghi S, Rezaei N.

Clin Rheumatol. 2017 Apr;36(4):831-836. doi: 10.1007/s10067-016-3466-8. Epub 2016 Nov 23.

PMID:
27878683
7.

APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

Chasset F, de Masson A, Le Buanec H, Xhaard A, de Fontbrune FS, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, Socié G, Bouaziz JD.

Haematologica. 2016 Jul;101(7):e312-5. doi: 10.3324/haematol.2016.145409. Epub 2016 Mar 18. No abstract available.

8.

Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.

Carvalho-Santos A, Ribeiro-Alves M, Cardoso-Weide LC, Nunes J, Kuhnert LR, Xavier AR, Cunha S, Hahne M, Villa-Verde DM, Carvalho-Pinto CE.

PLoS One. 2015 Oct 15;10(10):e0140150. doi: 10.1371/journal.pone.0140150. eCollection 2015.

9.

High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.

Lee C, Park JW, Suh JH, Moon KC.

Pathol Res Pract. 2015 Nov;211(11):824-8. doi: 10.1016/j.prp.2015.07.011. Epub 2015 Jul 20.

PMID:
26296917
10.

Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.

Weldon AJ, Moldovan I, Cabling MG, Hernandez EA, Hsu S, Gonzalez J, Parra A, Benitez A, Daoud N, Colburn K, Payne KJ.

J Rheumatol. 2015 May;42(5):749-59. doi: 10.3899/jrheum.140630. Epub 2015 Mar 1.

11.

APRIL induces cisplatin resistance in gastric cancer cells via activation of the NF-κB pathway.

Zhi X, Tao J, Xiang G, Cao H, Liu Z, Yang K, Lv C, Ni S.

Cell Physiol Biochem. 2015;35(2):571-85. doi: 10.1159/000369720. Epub 2015 Jan 27.

12.

Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.

Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Moniuszko M, Dzieciol J, Kloczko J.

Leuk Res. 2015 Mar;39(3):290-5. doi: 10.1016/j.leukres.2014.12.012. Epub 2014 Dec 27.

PMID:
25582383
13.

High APRIL expression correlates with unfavourable survival of gastrointestinal stromal tumour.

Xian H, Zhang H, Zhu H, Wang X, Tang X, Mao Y, Zhu J.

Pathology. 2014 Dec;46(7):617-22. doi: 10.1097/PAT.0000000000000162.

PMID:
25393252
14.

High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma.

Li YJ, Li ZM, Xia ZJ, Li S, Xia Y, Huang HQ, Huang JJ, Yi PY, Jiang WQ.

Ann Hematol. 2015 Jan;94(1):79-88. doi: 10.1007/s00277-014-2173-2. Epub 2014 Aug 22.

PMID:
25146008
15.

The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis.

Zhao J, Guo J, Wang L, Zhou W, Zhang Z.

Scand J Rheumatol. 2014;43(6):462-9. doi: 10.3109/03009742.2014.905630. Epub 2014 Jun 5.

PMID:
24898359
16.

Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.

Boghdadi G, Elewa EA.

Rheumatol Int. 2014 Sep;34(9):1217-23. doi: 10.1007/s00296-014-3020-4. Epub 2014 Apr 21.

PMID:
24748505
17.

High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer.

Qian Z, Qingshan C, Chun J, Huijun Z, Feng L, Qiang W, Qiang X, Min Z.

Am J Clin Pathol. 2014 Feb;141(2):226-33. doi: 10.1309/AJCP4JP8BZOMHEAW.

PMID:
24436270
18.

Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.

Zhang J, Ma L, Zhang SQ.

Protein Expr Purif. 2014 Mar;95:177-81. doi: 10.1016/j.pep.2013.12.013. Epub 2014 Jan 10.

PMID:
24412409
19.

The up-regulation expression of APRIL is a marker of glottic malignant disease.

Lian M, Fang J, Han D, Ma H, Wang R, Yang F.

Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2781-7. doi: 10.1007/s00405-013-2826-0. Epub 2013 Nov 26.

PMID:
24276470
20.

Raised expression of APRIL in Chinese children with acute lymphoblastic leukemia and its clinical implications.

Sun B, Wu Y, Wu L, Cui M, Ni H, Yang Z, Xu M, Wang H.

J Pediatr Hematol Oncol. 2014 May;36(4):276-80. doi: 10.1097/MPH.0b013e31829f3271.

PMID:
23887020

Supplemental Content

Support Center